- 公司资讯
- ESG评级中心 | 2024年11月21日 07:00新浪财经ESG：Vanda Pharmaceuticals Inc MSCI（明晟）ESG评级调降至CCC
- 智通财经APP | 2024年06月06日 20:08万达生物制药(VNDA.US)盘前涨近25% 传Cycle Pharmacecals提出每股8美元收购要约
- finviz | 2022年09月30日 04:30Vanda Pharmaceuticals and OliPass Announce Strategic Partnership to Develop Antisense Oligonucleotide Therapeutics
- finviz | 2022年09月09日 06:00Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference
- finviz | 2022年09月08日 06:38VANDA PHARMACEUTICALS ANNOUNCES NOTICE OF OPPORTUNITY FOR AN FDA HEARING ON THE sNDA FOR HETLIOZ
- finviz | 2022年09月04日 21:47Shareholders in Vanda Pharmaceuticals (NASDAQ:VNDA) are in the red if they invested five years ago
- finviz | 2022年08月04日 05:25Vanda Pharmaceuticals (VNDA) Q2 Earnings and Revenues Miss Estimates
- finviz | 2022年08月04日 04:01Vanda Pharmaceuticals Reports Second Quarter 2022 Financial Results
- finviz | 2022年07月28日 05:30Vanda Pharmaceuticals to Announce Second Quarter 2022 Financial Results on August 3, 2022
- finviz | 2022年07月06日 20:30Bluebird (BLUE) Surges 18%: Is This an Indication of Further Gains?
- finviz | 2022年07月05日 19:21Has Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
- finviz | 2022年06月03日 04:30Vanda Pharmaceuticals Announces Participation in the Jefferies 2022 Global Healthcare Conference
- finviz | 2022年06月01日 06:00Vanda Pharmaceuticals Announces Presentations at SLEEP 2022
- finviz | 2022年05月20日 07:00Vanda Pharmaceuticals Announces Presentations at DDW 2022
- finviz | 2022年05月06日 07:15Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates
- finviz | 2022年05月06日 04:10Vanda Pharmaceuticals Reports First Quarter 2022 Financial Results
首页
上页
下页